The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Study Type
OBSERVATIONAL
Enrollment
100
University of Miami
Miami, Florida, United States
RECRUITINGPositive CMV Immunoglobulin (IgG) positive lung transplant
Positive CMV Immunoglobulin (IgG) measured by IU/ml
Time frame: Up to 1 year
Graft Outcome status
Graft Outcome status measured by number of rejection based on forced expiratory volume in 1 second( FEV1) /Forced vital capacity (FVC) ratio. A calculated ratio that helps diagnose obstructive and restrictive lung diseases
Time frame: Up to 1 year
Number of dead participants
Number of dead participants measured by numbers of death
Time frame: Up to 1 year
Duration of CMV medication
Duration of CMV medication measured by treatment days
Time frame: Up to 1 year
Number of patients with CMV-positive results
CMV disease measured by the number of patients with CMV-positive results
Time frame: Up to 1 year
Severity of CMV Disease
Severity of CMV disease measured by CMV polymerase chain reaction (PCR) (IU/mL)
Time frame: Up to 1 year
Severity of Torque Teno virus
Severity of Torque Teno virus measured by Torque Teno virus (TTV) (BAU/ml)
Time frame: Up to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.